According to Eurobio Scientific's latest financial reports the company has $76.89 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $92.03 M | -20.63% |
2021-12-31 | $0.11 B | 43.8% |
2020-12-31 | $80.63 M | 844.75% |
2019-12-31 | $8.53 M | -32.21% |
2018-12-31 | $12.59 M | -11.04% |
2017-12-31 | $14.15 M | 70.04% |
2016-12-31 | $8.32 M | -34.86% |
2015-12-31 | $12.77 M | -25.63% |
2014-12-31 | $17.18 M | 118.52% |
2013-12-31 | $7.86 M | -39.36% |
2012-12-31 | $12.96 M | -22.6% |
2011-12-31 | $16.75 M | -50.82% |
2010-12-31 | $34.06 M | -21.4% |
2009-12-31 | $43.33 M | 47.26% |
2008-12-31 | $29.42 M | -35.7% |
2007-12-31 | $45.76 M |